ID: ALA425011
Chembl Id: CHEMBL425011
PubChem CID: 44399920
Max Phase: Preclinical
Molecular Formula: C29H47N3OS
Molecular Weight: 485.78
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCCCCCCCCCCNC(=O)[C@H]1CSC(c2ccc(C#N)cc2)N1
Standard InChI: InChI=1S/C29H47N3OS/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-22-31-28(33)27-24-34-29(32-27)26-20-18-25(23-30)19-21-26/h18-21,27,29,32H,2-17,22,24H2,1H3,(H,31,33)/t27-,29?/m1/s1
Standard InChI Key: YHEFEPKLEKOFIQ-SCBLGKRXSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 485.78 | Molecular Weight (Monoisotopic): 485.3440 | AlogP: 7.64 | #Rotatable Bonds: 19 |
| Polar Surface Area: 64.92 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
| #RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: ┄ | CX Basic pKa: 6.12 | CX LogP: 8.60 | CX LogD: 8.58 |
| Aromatic Rings: 1 | Heavy Atoms: 34 | QED Weighted: 0.20 | Np Likeness Score: -0.53 |
| 1. Gududuru V, Hurh E, Dalton JT, Miller DD.. (2005) Discovery of 2-arylthiazolidine-4-carboxylic acid amides as a new class of cytotoxic agents for prostate cancer., 48 (7): [PMID:15801848] [10.1021/jm049208b] |
Source(1):
